Literature DB >> 17627566

Beneficial effects of statins on endothelial dysfunction and vascular stiffness.

Polychronis Dilaveris1, Georgios Giannopoulos, Maria Riga, Andreas Synetos, Christodoulos Stefanadis.   

Abstract

Endothelial dysfunction and increased arterial stiffness are considered independent predictors of cardiovascular risk. Endothelial dysfunction primarily reflects decreased availability of nitric oxide, a critical endothelium-derived vasoactive factor with vasodilatory and anti-atherosclerotic properties. Techniques for assessing endothelial dysfunction include ultrasonographic measurement of flow-mediated vasodilatation of the brachial artery and plethysmographic measurement of forearm blood flow responses to vasoactive agents. Arterial stiffness can be assessed using pulse wave analysis to generate measures of pulse wave velocity, arterial compliance and wave reflection. It has been demonstrated that the preventive effect of statins on coronary events is not only attributed to cholesterol-lowering, but also to various effects on the vascular wall, which include improved endothelial function as well as antioxidant and anti-inflammatory activity. Previous studies have reported improvement of arterial stiffness by the antioxidant and anti-inflammatory effects of statin therapy in patients with or without hypercholesterolemia. The present review considers the pathophysiology underlying endothelial dysfunction and increased arterial stiffness associated with atherosclerotic disease and the beneficial effects of statins on these markers of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627566     DOI: 10.2174/157016107781024091

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  24 in total

1.  Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease.

Authors:  Kristen L Nowak; Heather Farmer; Melissa A Cadnapaphornchai; Berenice Gitomer; Michel Chonchol
Journal:  Nephrol Dial Transplant       Date:  2017-02-01       Impact factor: 5.992

2.  Impact of metabolic indices on central artery stiffness: independent association of insulin resistance and glucose with aortic pulse wave velocity.

Authors:  D R Webb; K Khunti; R Silverman; L J Gray; B Srinivasan; P S Lacy; B Williams; M J Davies
Journal:  Diabetologia       Date:  2010-03-06       Impact factor: 10.122

Review 3.  Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review.

Authors:  Peter Adegbola; Ifewumi Aderibigbe; Wasiu Hammed; Tolulope Omotayo
Journal:  Am J Cardiovasc Dis       Date:  2017-04-15

4.  Influence of exercise and perivascular adipose tissue on coronary artery vasomotor function in a familial hypercholesterolemic porcine atherosclerosis model.

Authors:  Aaron K Bunker; M Harold Laughlin
Journal:  J Appl Physiol (1985)       Date:  2009-12-03

5.  Hypercholesterolemia and microvascular dysfunction: interventional strategies.

Authors:  Phoebe A Stapleton; Adam G Goodwill; Milinda E James; Robert W Brock; Jefferson C Frisbee
Journal:  J Inflamm (Lond)       Date:  2010-11-18       Impact factor: 4.981

6.  Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo.

Authors:  Hyoung Chul Choi; Ping Song; Zhonglin Xie; Yong Wu; Jian Xu; Miao Zhang; Yunzhou Dong; Shuangxi Wang; Kai Lau; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

7.  Diabetes reduces aortic endothelial gap junctions in ApoE-deficient mice: simvastatin exacerbates the reduction.

Authors:  Charles Jia-Yin Hou; Cheng-Ho Tsai; Cheng-Huang Su; Yih-Jer Wu; Su-Jen Chen; Jing-Jing Chiu; Ming-Shi Shiao; Hung-I Yeh
Journal:  J Histochem Cytochem       Date:  2008-04-28       Impact factor: 2.479

8.  eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity.

Authors:  S Nagassaki; R D Herculano; C F O Graeff; J E Tanus-Santos
Journal:  Eur J Clin Pharmacol       Date:  2008-12-23       Impact factor: 2.953

9.  Highly active antiretroviral therapy drugs inhibit in vitro cholesterol efflux from human macrophage-derived foam cells.

Authors:  Xinwen Wang; Dan Liao; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Lab Invest       Date:  2009-09-21       Impact factor: 5.662

10.  HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.

Authors:  Jung-Won Suh; Dong-Ju Choi; Hyuk-Jae Chang; Young-Seok Cho; Tae-Jin Youn; In-Ho Chae; Kwang-Il Kim; Cheol-Ho Kim; Hyo-Soo Kim; Buyng-Hee Oh; Young-Bae Park
Journal:  J Korean Med Sci       Date:  2009-12-26       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.